Pediatric Hematologist/Oncologist (Child Cancer Specialist)
Dr. Milner's research focus is graft manipulation. The utilization of graft manipulation permits decreased morbidities and improved quality of life in stem cell transplant recipients.
This research study is being done to determine the safety and tolerability of increasing doses of defibrotide within a single patient with sinusoidal obstructive syndrome (SOS)/veno-occlusive disease (VOD) after hematopoietic cell transplantation…
Hematopoietic stem cell transplantation can cure patients with blood cancer and other underlying diseases. αβ-T cell and B cell depletion has been introduced to decrease GVHD and PTLD and has demonstrated effectiveness for hematologic malignancies…
A Phase I trial to determine the safety of targeted immunotherapy with daratumumab (DARA) IV after total body irradiation (TBI)-based myeloablative conditioning and allogeneic hematopoietic cell transplantation (HCT) for children, adolescents, and…
10 publications
2026
International journal of particle therapy
PubMed • Publisher's site2024
Leukemia research reports
PubMed • Publisher's site2024
Pediatric transplantation
PubMed • Publisher's site2024
Frontiers in Neurology
PubMed • Publisher's site2023
Blood
Publisher's site